Cite
HARVARD Citation
Hill, J. et al. (n.d.). LB1. Remdesivir for the Treatment of High-Risk Non-Hospitalized Individuals With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial. Open forum infectious diseases. pp. S806-S807. [Online].